Page not found

The page you were looking for does not exist. Please try searching for what you're looking for.

Search results

  1. complex than some people might think. Most patients diagnosed with the most common kind of esophageal ... with Barrett's esophagus? “It can affect people in different ways,” Shah said, adding that patients should also ... effects, and the procedure has an extremely high patient success rate. This procedure is known ...

  2. Cancer Clinical Trial PCRT 12-001

    Nab-Paclitaxel+Cisplatin+Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA) Purpose: ... gemcitabine for patients with metastatic pancreatic ductal adenocarcinoma (PDA). Inclusion Criteria: Age ... at the Screening Visit and be non-lactating. Both male and female patients of reproductive potential must agree ...

  3. Can long-term acid reflux cause cancer?

    patients diagnosed with the most common kind of esophageal cancer typically experience a series ... ways,” Shah said, adding that patients should also pay attention to the following risk factors: Have you ... and the procedure has an extremely high patient success rate. This procedure is known as radiofrequency ablation. ...

  4. Study investigates detecting pancreatic cancer early

    Risk Assessment Program, researchers are identifying patients at average, moderate and high risk ... is that these patients are identified as being at risk for pancreatic cancer, but are not followed in a consistent ... manner. We want to make sure that patients in this study are being monitored with the collaboration ...

  5. are identifying patients at average, moderate and high risk of developing pancreatic cancer and following them ... identified as high risk for the disease. “What often happens is that these patients are identified as being ... that patients in this study are being monitored with the collaboration of a multidisciplinary team,” Dr. ...

  6. Cancer Clinical Trial- MacroGenics CP-MGA012-01

    and Pharmacokinetics of MGA012 in Patients With Advanced Solid Tumors The primary goal of this Phase 1 study ... administered on either every two week or every four schedules of administration among patients with solid ... laboratory parameters Symptomatic central nervous system (CNS) metastases. For Cohort Expansion, patients who ...

  7. Phase 1, dose escalation study of oral ARQ 087 for patients with advanced solid tumors Adrenal Cortical ... of oral ARQ 087 for patients with advanced solid tumors Anal Canal MK3475-028-00 Merck Study of MK-3475 ... 673, a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation Breast ...

  8. HonorHealth - Essential Touch exercise physiologist and patient Want to live a healthier lifestyle? ... Our exercise specialists have extensive experience working with special patient needs, ...

  9. commitment to improving the delivery of care for patients with serious or life-threatening injuries, ... clinical community. Ultimately, the goals of the studies are to lead to better patient care and outcomes. ...

  10. the Safety and Tolerability of GDC-0032 in Patients With Locally Advanced or Metastatic Solid Tumors ... And in Combination With Endocrine Therapy in Patients With Locally Advanced or Metastatic Hormone Receptor-Positive ...